SALVIA BIOELECTRONICS BV

Their core work

Salvia BioElectronics is a Dutch SME based in Eindhoven that develops bioelectronic medical devices, with a strong focus on smart catheters and implantable electronics. They specialize in microfabrication techniques applied to medical devices, contributing to pilot production lines that bridge the gap between lab prototypes and volume manufacturing. Their work spans intravascular imaging and diagnostics (IVUS, FFR, ICE) as well as next-generation implantable systems. As a participant in large-scale ECSEL and Innovation Action pilot lines, they contribute specialized bioelectronics expertise to Europe's medical device manufacturing ecosystem.

What they specialise in

How they've shifted over time

Salvia BioElectronics entered H2020 through InForMed (2015), a broad micro-fabricated medical device pilot line with no specific keyword specialization recorded. By their second and third projects (2018 onward), their focus sharpened considerably toward smart catheters, intravascular diagnostics (IVUS, FFR, ICE), and implantable devices. The progression shows a company moving from general microfabrication participation toward a defined niche in interventional cardiology devices and open platform architectures for medical technology.

Salvia is deepening its specialization in catheter-based diagnostics and implantable bioelectronics, while also moving toward open, reusable technology platforms — positioning them for modular medtech development.

How they like to work

Salvia BioElectronics operates exclusively as a participant, never as coordinator, which is typical for a specialized SME contributing domain expertise to large pilot-line consortia. Their 109 unique partners across 15 countries reflect the massive scale of ECSEL-type projects rather than individually curated partnerships. Working with them means engaging a focused technical contributor that integrates well into large, industry-driven consortia without needing to lead the administrative burden.

Through three large-scale pilot line projects, Salvia has built connections with 109 unique partners across 15 countries — an extensive European network concentrated in the semiconductor and medical device manufacturing ecosystem centered around ECSEL consortia.

What sets them apart

Salvia BioElectronics sits at the intersection of semiconductor microfabrication and medical device development — a niche where few European SMEs operate. Based in Eindhoven, they benefit from proximity to the Dutch high-tech ecosystem (Philips, NXP, ASML) while maintaining the agility of a small company. For consortium builders, they offer specialized bioelectronics know-how for catheter and implant development without the overhead of engaging a large corporate partner.

Highlights from their portfolio

• POSITION-II
  Largest funding (EUR 519,798) and most technically specific project, targeting next-generation smart catheters with defined clinical modalities (IVUS, FFR, ICE).
• Moore4Medical
  Most recent project (2020-2023) focused on accelerating microfabricated medical device innovation, signaling continued commitment to scaling medtech manufacturing.